Figure 6
The degree of gliadin deamidation was measured by an anti-body based ELISA. A pilot experiment was conducted to confirm the inhibitory effect of ascorbyl palmitate on TG2 activity. There was no significant difference between TG2 processed ascorbyl palmitate treated gliadin and the unprocessed gliadin control (p = 0.75). No effect of ZnCl2 could be observed since TG2 activity was already silenced. The letters a, b, c indicate significant differences between deamidated and non-deamidated gliadin.
